Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-07-01Clinical Trial Update: Metformin for the Prevention of Episodic Migraine (MPEM) [Phase 3]
A Phase 3 trial investigating metformin for the prevention of episodic migraine has completed and posted results in 2020.
-
FDA approval · 2020-06-24FDA Approved: SUMATRIPTAN AND NAPROXEN SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for the generic Sumatriptan and Naproxen Sodium from Aurobindo Pharma Limited.
-
FDA approval · 2020-06-09FDA Approved: ZOLMITRIPTAN — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Zolmitriptan filed by Zydus Pharmaceuticals USA Inc., indicating regulatory approval for a m…
-
CLINICAL_TRIALS withdrawal · 2020-06-01Clinical Trial Update: Study of Quality of Life in Subjects With Chronic or High-frequency Episodic Migraine and Associated Comorbidities Treated With Erenumab [Phase 3]
A Phase 3 study evaluating quality of life in chronic or high-frequency episodic migraine patients treated with erenumab has been withdrawn.
-
FDA approval · 2020-05-20FDA Approved: DIHYDROERGOTAMINE MESYLATE NASAL — Original Application (Cipla USA Inc.)
The FDA approved Cipla's dihydroergotamine mesylate nasal spray as an original generic application, making a generic version of the acute mi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-05-19FDA Approved: DEPAKOTE SPRINKLES — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Depakote Sprinkles (divalproex sodium) from AbbVie, updating labeling/indications for the pr…
-
FDA approval · 2020-05-08FDA Approved: IBUPROFEN — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's ibuprofen generic under Original Application (ANDA213794). The product is a generic version of ibupr…
-
FDA label_change · 2020-04-30FDA Approved: AIMOVIG — Supplemental Application (Amgen Inc)
The FDA approves a supplemental application for AIMOVIG (erenumab-aooe) from Amgen, resulting in a labeling change.
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Efficacy and Safety Study of Dysport® Used for Migraine Prophylaxis [Phase 2]
Phase 2 study assessing efficacy and safety of Dysport for migraine prophylaxis has completed.
-
FDA approval · 2020-04-21FDA Approved: VALPROIC ACID — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved a supplemental application for valproic acid (generic) submitted by Chartwell Governmental & Specialty RX, LLC.
-
CLINICAL_TRIALS trial_result · 2020-04-21Clinical Trial Update: An Open Label Trial of ALD403 (Eptinezumab) in Chronic Migraine [Phase 3]
Open-label Phase 3 trial of ALD403 (eptinezumab) in chronic migraine completed; results posted in 2020.
-
FDA approval · 2020-04-13FDA Approved: SUMATRIPTAN SUCCINATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Sumatriptan Succinate from Sun Pharmaceutical Industries, Inc., indicating regulatory approval r…
-
FDA approval · 2020-04-09FDA Approved: TOPIRAMATE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Topiramate from Zydus Lifesciences Limited under ANDA207382, granting additional approval relate…
-
FDA approval · 2020-04-08FDA Approved: BUTALBITAL, ACETAMINOPHEN AND CAFFEINE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved the original application for a generic fixed-dose combination of butalbital, acetaminophen, and caffeine (Granules Pharmaceutic…
-
CLINICAL_TRIALS trial_result · 2020-04-07Clinical Trial Update: Ginger Capsules for the Acute Treatment of Migraine Attacks [NA]
A completed clinical trial evaluating ginger capsules for acute treatment of migraine attacks; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-30Clinical Trial Update: A Multicenter Assessment of ALD403 in Chronic Migraine [Phase 2]
Phase 2 multicenter trial assessing ALD403 for chronic migraine has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-03-27Clinical Trial Update: Trial in Adult Subjects With Acute Migraines [Phase 3]
Phase 3 clinical trial in adults with acute migraine (with or without aura) completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-27Clinical Trial Update: A Study Investigating the Efficacy of GON Blocks. [Phase 4]
A Phase 4 clinical trial investigating the efficacy of GON Blocks completed, with results pending or not specified in the snippet.
-
CLINICAL_TRIALS trial_result · 2020-03-25Clinical Trial Update: Acetaminophen and Ibuprofen With and Without Magnesium and Primary Migraine in Childhood [Phase 4]
Phase 4 clinical trial investigating acetaminophen and ibuprofen, with and without magnesium, for primary migraine in childhood; results pos…
-
FDA approval · 2020-03-24FDA Approved: RELPAX — Supplemental Application (ROERIG)
FDA approves a supplemental application for RELPAX (eletriptan hydrobromide) submitted by ROERIG.
-
FDA approval · 2020-03-16FDA Approved: NARATRIPTAN — Supplemental Application (Bionpharma Inc.)
The FDA approved a supplemental application for Naratriptan submitted by Bionpharma Inc., signaling an updated approval for Naratriptan prod…
-
FDA approval · 2020-02-28FDA Approved: DIHYDROERGOTAMINE MESYLATE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved an original-application generic formulation of dihydroergotamine mesylate from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2020-02-27FDA Approved: NURTEC ODT — Original Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approves Nurtec ODT (rimegepant sulfate) under its original NDA for the acute treatment of migraine in adults.
-
FDA approval · 2020-02-27FDA Approved: EXCEDRIN MIGRAINE GELTABS — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for Excedrin Migraine Geltabs (acetaminophen, aspirin, caffeine) submitted by Haleon US Holdings LLC…
-
FDA approval · 2020-02-21FDA Approved: VYEPTI — Original Application (Lundbeck Pharmaceuticals LLC)
FDA approved VYEPTI (eptinezumab-jjmr) under an original Biologics License Application for the preventive treatment of chronic migraine in a…